Enliven Therapeutics (ELVN) Earnings Date & Reports
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ELVN is expected to report earnings to fall 4.35% to -54 cents per share on August 07
Q2'25
Est.
$-0.55
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.14
The last earnings report on May 14 showed earnings per share of -56 cents, missing the estimate of -50 cents. With 345.76K shares outstanding, the current market capitalization sits at 1.06B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ELVN showed earnings on May 14, 2025. You can read more about the earnings report here.